Biography1993: MD, University of Paris, France
1994-1996: Assistant Professor in Medicine, Paris, France (specialty nuclear medicine)
1996-2002: Research and Clinical Fellowship, Cardiac Ultrasound Laboratory, MGH, Boston
2002-2003: Instructor in Medicine, Harvard Medical School, Boston
Clinical Assistant, Cardiac Ultrasound Laboratory, MGH, Boston
2003-2010: Assistant Professor in Medicine, Harvard Medical School, Boston
2006-2007: Assistant, Cardiac Ultrasound Laboratory, MGH, Boston
2007- : Assistant Physician, Cardiac Ultrasound Laboratory, MGH, Boston
2010- : Associate Professor in Medicine, Harvard Medical School, Boston
I am a cardiologist, and spend 40% time in clinicalechocardiography and 60% time in the research laboratory (10% time in bothsettings dedicated to teaching). My research interest is to further theunderstanding of heart failure progression; echocardiography is a crucial toolthat allows me to link signaling pathways to the organ level, and apply basicresearch findings to clinical research.
One particular topic of interest in my research has been to better understand the role of nitric oxide in the development of heart failure. As obesity is affecting an increasing proportion of the western societies, Iwanted to study the interaction between metabolic challenges, heart functionand nitric oxide.
Furthermore, I develop, validate and lead the platform ofmouse echocardiography as a tool to better build up noninvasive diagnosticmodalities that further the understanding of heart failure in humans. Some ofmy recent work applies echocardiographic indices of myocardial function frommice to humans. Using findings in a mouse model of chemotherapy-induced cardiotoxicity, we validated echocardiography as a predictor of later cardiotoxicity. I am now the principal investigator on a multicenter prospective study assessing similar indices in women with breast cancer.
out of 90
Nitric Oxide Synthase 3 limits left ventricularremodeling after myocardial infarction in mice. Circulation2001
A short duration of high-fat diet induces insulin resistance andpredisposes to adverse left ventricular remodeling after pressureoverload. Am JPhysiol Heart Circ Physiol. 2008
Early Detection and Prediction ofCardiotoxicity in Chemotherapy-Treated Patients. Circulation CV imaging 2012
The Massachusetts General Hospital Cardio-Oncology Program is honored by the Mass General Cancer Center for its work in the diagnosis, treatment and prevention of cardiovascular disease related to chemotherapy or radiotherapy.
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.